echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Hefei: the profit margin of foreign drugs accounted for 70% of the score, and the price was reduced by at least 6%!

    Hefei: the profit margin of foreign drugs accounted for 70% of the score, and the price was reduced by at least 6%!

    • Last Update: 2015-06-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: sabilan 2015-06-08 on June 5, the website of Hefei Health Bureau of Anhui Province released the announcement on the volume purchase of imported and joint venture varieties of drugs by Hefei medical institutions After the introduction of Bengbu's purchasing plan with volume, Anhui has set off a "price cutting boom" The current purchase of drugs with volume in Hefei is still a price reduction act under the guise of "purchase with volume" and taking "second negotiation" as the essence At least 15% of the price of 12 varieties will be reduced According to the clinical requirements of each unit, the specifications of commonly used dosage forms, and the principle of priority of national basic drugs, Anhui basic drugs and bid winning drugs, 19 medical institutions of the municipal union will evaluate and summarize the reported data to form 12 competitive products The contents are as follows: the scoring rules are as follows: Compared with 70% of the score, Hefei is the most ruthless in terms of foreign drugs and imports At the same time, Hefei also issued a notice on the volume purchase of imported and joint venture varieties "The margin of interest yield is 6% - 12% The highest percentage of yield interest is 70 points, and other values are calculated according to the percentage with the highest score " Note that this is the original of the bidding document Compared with Suzhou, the score of profit margin is 50%, Bengbu, 40%, and Hefei, 70% For this, the editor can only ha ha It's better to reduce the price by 100% directly 6% - 12% of the imported drugs have been forced to yield profits In the announcement of drug volume purchase in Hefei, the requirement of yield margin is slightly milder than that in Bengbu and Fuyang Bengbu directly kicked out of the market with a single variety yield of less than 25% and other yield of less than 15% Fuyang is the direct out of pharmaceutical companies with profit margin less than 20% Hefei's requirement for profit margin is between 6% and 12%, but its highlight lies in the purchase of imported and joint-venture varieties in separate packaging Under such a sharp tool, how many of these foreign-funded enterprises will respond to the bidding?
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.